Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles
Diabetes, Obesity and Metabolism · 2026
DOI: 10.1111/dom.70767 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Sixtus Aguree und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Health Science, School of Public Health-Bloomington, Indiana University, Bloomington, Indiana, USA. Hauptthemen laut MEDLINE: Asthma, Inflammation, Diabetes Mellitus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, AHRQ HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aims
Asthma and diabetes frequently co‐occur and share metabolic and inflammatory features, yet the cardiometabolic profile associated with their coexistence is not well defined. We examined differences in cardiometabolic and inflammatory biomarkers by joint asthma–diabetes status in U.S. adults and evaluated whether current asthma modifies diabetes‐associated alterations.
Methods
We conducted a cross‐sectional analysis of 5295 non‐pregnant adults aged 20–85 years from NHANES 2015–2020 with complete fasting data. Participants were categorized as having neither condition (77.0%), asthma only (7.0%), diabetes only (14.1%), or both conditions (1.9%). Survey‐weighted multivariable linear regression estimated associations with glycaemic, lipid, insulin‐resistance and inflammatory biomarkers. Multiplicative and additive interactions were assessed using product terms and the relative excess risk due to interaction (RERI). Models were adjusted for sociodemographic and behavioural factors and waist circumference.
Results
Participants with both asthma and diabetes displayed the most adverse biomarker profile. Compared with those with neither condition, the comorbid group had higher fasting glucose ( β 58.86 mg/dL, 95% CI 45.49–72.23), HbA1c ( β 1.70%, 95% CI 1.38–2.03), HOMA‐IR ( β 5.93, 95% CI 3.43–8.42), TyG index ( β 0.75, 95% CI 0.56–0.95) and ln(triglycerides) ( β 0.35, 95% CI 0.14–0.56). The largest differences were observed for inflammatory markers, including ln(hs‐CRP) ( β 0.74, 95% CI 0.35–1.12) and hs‐CRP ( β 6.88 mg/L, 95% CI 2.08–11.67). Adjusted predicted means for fasting glucose (158.8 mg/dL, 95% CI 144.9–172.8) and HbA1c (7.07%, 95% CI 6.74–7.41) were also highest in the comorbid group. Multiplicative interaction tests indicated no interaction for glycaemic or lipid outcomes; significant interactions were limited to HDL‐C ( p = 0.039) and SIRI ( p = 0.003), both reflecting sub‐additive effects. No additive interaction remained significant after multiple‐testing correction.
Conclusions
Coexisting asthma and diabetes are associated with a substantially greater burden of dysglycaemia, insulin resistance and inflammation than either condition alone. However, formal interaction analyses suggest that these joint effects are not synergistic and instead follow additive or sub‐additive patterns.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Applied Health Science, School of Public Health-Bloomington, Indiana University, Bloomington, Indiana, USA.
- Department of Environmental and Occupational Health, School of Public Health-Bloomington, Indiana University, Bloomington, Indiana, USA.
- Division of Pulmonary, Critical Care, Sleep, and Occupational Medicine, Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
- Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington, Indiana, USA.
- Department of Pediatrics, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
- Department of Medicine, School of Medicine, Indiana University, Indianapolis, Indiana, USA.
ORCID-Profile: Sixtus Aguree
Förderung
- NHLBI NIH HHS
- NHGRI NIH HHS
- AHRQ HHS
Zitieren
APA
Aguree, S., Silveyra, P., Liu, N., Owora, A. H., & Mersha, T. B. (2026). Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70767
Vancouver
Aguree S, Silveyra P, Liu N, Owora AH, Mersha TB. Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70767
BibTeX
@article{Aguree2026,
author = {Aguree, Sixtus and Silveyra, Patricia and Liu, Nianjun and Owora, Arthur H and Mersha, Tesfaye B},
title = {Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles},
journal = {Diabetes, Obesity and Metabolism},
year = {2026},
doi = {10.1111/dom.70767}
}
EUVIMED